Sign in

CIK 0001053369

  • Non-accelerated filer
  • Smaller reporting company

ELITE PHARMACEUTICALS INC /NV/

Sign in to watch
Ticker
ELTP
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NJ
Entity type
Operating
EIN
223542636
Phone
+1 201-750-2646
Business address
165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
Former names
ELITE PHARMACEUTICALS INC /DE/
Open-market buys, last 90 days
$25,980
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$25,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dash Barry H +$26K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2012-12-26 EPIC INVESTMENTS, LLC 10% owner Sale −561,000 $0.09 $51K 9,328,002
2012-12-21 POTTI RAM Director Other disposition −17,005,400 $0.04 $627K 10,120,655
2012-12-21 POTTI RAM Director Other disposition · Warrants −8,366,667 15,135,332
2012-12-21 NIGALAYE ASHOK G Chief Scientific Officer Other disposition −17,005,420 $0.04 $627K 10,528,604
2012-12-21 NIGALAYE ASHOK G Chief Scientific Officer Other disposition · Warrants −8,366,667 15,135,332
2012-12-21 NARINE JEENARINE Director Other disposition −17,005,400 $0.04 $627K 10,528,584
2012-12-21 NARINE JEENARINE Director Other acquisition · Warrants +8,366,667 15,135,332
2012-12-21 EPIC PHARMA LLC 10% owner Other acquisition +17,005,400 $0.04 $627K 9,889,002
2012-12-21 EPIC PHARMA LLC 10% owner Other acquisition · Warrants +8,366,667 15,135,332
2012-12-21 EPIC INVESTMENTS, LLC 10% owner Other disposition −17,005,420 $0.04 $627K 9,889,002
2012-12-21 EPIC INVESTMENTS, LLC 10% owner Other disposition · Warrants −8,366,667 15,135,332
2012-12-19 POTTI RAM Director Sale −243,300 $0.09 $22K 27,126,055
2012-12-19 NIGALAYE ASHOK G Chief Scientific Officer Sale −243,300 $0.09 $22K 27,534,004
2012-12-19 NARINE JEENARINE Director Sale −243,300 $0.09 $22K 27,534,004
2012-12-19 EPIC PHARMA LLC 10% owner Sale +243,300 $0.09 $22K 26,894,422
2012-12-19 EPIC INVESTMENTS, LLC 10% owner Sale −243,300 $0.09 $22K 26,894,442
2012-12-10 Ward Carter Julian Chief Financial Officer, Sec. Sale −201,192 $0.08 $16K 1,669,555
2012-09-10 NARINE JEENARINE Director Grant or award · Series E Convertible Preferred Stock +250 $1,000.00 $250K 2,187.5
2012-09-10 NIGALAYE ASHOK G Chief Scientific Officer Grant or award · Series E Convertible Preferred Stock +250 $1,000.00 $250K 2,187.5
2012-09-10 POTTI RAM Director Grant or award · Series E Convertible Preferred Stock +250 $1,000.00 $250K 2,187.5

Page 20 of 28 · 542 trades